An estimated 20-30% of the four million Americans with hepatitis C infection (HCV) are projected to develop advanced fibrosis and cirrhosis after 2-3 decades of infection. Differences in exposure to fibrosis-promoting risk factors like alcohol abuse likely explain some of this difference in fibrosis risk. However, current research suggests that genetic factors may also influence the risk of advanced fibrosis in HCV patients. Two factors that research has repeatedly shown to be associated with development of advanced liver disease are male gender and abdominal obesity. However, the specific role genetic factors, including those related to male sex hormone receptor or androgen receptors (AR) and to insulin resistance (IR) associated with abdominal obesity, may play in fibrosis risk remains unclear. The goal of the proposed study is to ascertain the role that changes in AR and IR genes play in increasing risk of advanced fibrosis. The associated specific aims are: 1) to identify and collect data on a large and representative cohort of male veterans with HCV infection;2) to test the hypothesis that 'high risk" variants of genes related to IR either alone or in conjunction with abdominal obesity increase fibrosis risk;and 3) to test the hypothesis that 'high risk'variants of genes related to AR also increase fibrosis risk.
Aim 1 will be accomplished with standard epidemiology methods for cohort identification and will be performed at the Michael E. DeBakey VA.
Aims 2 and 3 will be addressed through a case-control study in which cohort members with advanced fibrosis (cases) are compared to those with mild fibrosis (controls). The research plan, didactic training and outstanding mentoring environment will work together to allow the principal investigator to acquire new skills as well as refine existing skills in the development and execution of novel genetic epidemiology studies, allowing her to develop into an independent investigator in genetic epidemiology of chronic liver and digestive disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
5K01DK081736-05
Application #
8319548
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Podskalny, Judith M,
Project Start
2008-09-15
Project End
2013-08-31
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
5
Fiscal Year
2012
Total Cost
$157,257
Indirect Cost
$11,649
Name
Baylor College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Kanwal, Fasiha; White, Donna L; Tavakoli-Tabasi, Shahriar et al. (2014) Many patients with interleukin 28B genotypes associated with response to therapy are ineligible for treatment because of comorbidities. Clin Gastroenterol Hepatol 12:327-333.e1
Tyson, Gia L; Richardson, Peter A; White, Donna L et al. (2013) Dietary fructose intake and severity of liver disease in hepatitis C virus-infected patients. J Clin Gastroenterol 47:545-52
White, D L; Tavakoli-Tabasi, S; Kanwal, F et al. (2013) The association between serological and dietary vitamin D levels and hepatitis C-related liver disease risk differs in African American and white males. Aliment Pharmacol Ther 38:28-37
Li, Linda T; Mills, Whitney L; White, Donna L et al. (2013) Causes and prevalence of unplanned readmissions after colorectal surgery: a systematic review and meta-analysis. J Am Geriatr Soc 61:1175-81
White, Donna L; Tavakoli-Tabasi, Shariar; Kuzniarek, Jill et al. (2012) Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males. Hepatology 55:759-68
White, Donna L; Richardson, Peter A; Al-Saadi, Mukhtar et al. (2011) Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis C infection. Dig Dis Sci 56:1835-47
White, D L; Savas, L S; Daci, K et al. (2010) Trauma history and risk of the irritable bowel syndrome in women veterans. Aliment Pharmacol Ther 32:551-61